A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 43 of the 122 sources its claims cite were checked for support.
Abstract
In this survey, we review the current state of the art in mathematical modeling of the menstrual cycle. We compare and contrast different modeling choices and the benefits and limitations of various models. We investigate the sensitivity of these models to variations in parameter values, highlighting that these models display particular sensitivity to the growth rate of the reserve pool of follicular stimulating hormone. We also describe the incorporation of time delays in the model equations and discuss the ways in which these delays reflect the biological system and impact the dynamics. We explore the qualitative effects that introducing exogenous hormones into these models plays on inducing a contraceptive state. Through our comparative study of these models, we are able to highlight important areas of future work in the mathematical modeling of hormonal contraception and the menstrual cycle.
Overview
CoChat Summary
TL;DR
This chapter surveys mechanistic mathematical models of the menstrual cycle, with emphasis on how hormonal contraception has been incorporated. It compares four Selgrade-lineage models, showing sensitivity to FSH reserve-pool growth rate, different delay/inhibin formulations, and varied contraceptive responses.
Key findings
- In the four implemented models (Harris Clark et al. 2003, Margolskee and Selgrade 2011, Wright et al. 2020, Gavina et al. 2023), increasing the maximum FSH reserve-pool growth rate \(V_{FSH}\) shortens the simulated cycle period, while lowering it generally lengthens the period; a 25% reduction in \(V_{FSH}\) caused loss of periodicity in the Gavina, Margolskee, and Harris Clark models.
- The Harris Clark model shows a non-smooth period change when \(V_{FSH}\) falls below 0.966 of its nominal 5700 μg/day, with loss of the estradiol secondary luteal peak; an example at \(V_{FSH}=5415\) μg/day is given.
- Delay handling varies: the original Selgrade–Schlosser model used delays \(d_E=0.42\) day, \(d_P=2.9\) days, and \(d_{Ih}=2\) days; Margolskee and Selgrade reduced this to a single \(\tau=1.5\)-day inhibin delay, and Wright et al. and Gavina et al. kept that \(\tau=1.5\)-day delay in the InhA input.
- Contraceptive responses differ: Wright et al. found low doses of combined synthetic progesterone and estrogen most effective and achieved total contraception for large enough doses; Gavina et al. reported about 92% dosage reduction in estrogen monotherapy and 43% in progesterone monotherapy, with mid-follicular estrogen delivery most effective, but also found LH peak increases for large estrogen doses. Harris Clark et al. achieved biological contraception for estrogen dose >20 and total contraception only at very large estrogen doses, while Margolskee and Selgrade did not achieve total contraception in tested ranges.
Methods
- Design: a survey and comparative analysis of mechanistic menstrual-cycle models, focusing on the Selgrade lineage and on models incorporating GnRH; the authors implement and compare four models: Harris Clark et al. [41], Margolskee and Selgrade [45], Wright et al. [46], and Gavina et al. [47].
- Data: the reviewed models are fit to two commonly used data sets, McLachlan et al. [9] and Welt et al. [12]; both followed approximately 40 women with regular cycles around 25–35 days and collected daily blood samples during one complete cycle. Welt et al. reported separate inhibin A and inhibin B, while McLachlan et al. reported total inhibin.
- Analysis: sensitivity analysis varied all parameters one at a time by 25% and used numerically approximated period length as the metric; heatmaps varied exogenous estrogen up to each model’s mean endogenous estradiol and exogenous progesterone up to 0.3 of mean endogenous progesterone, with simulations run for 100 cycles before computation.
Limitations
- The paper states that existing models do not incorporate the high variability in hormone levels within and between individuals, that many parameters cannot be inferred from data, and that parameters sharing names across models may differ in units or order of magnitude; a unit mismatch in Margolskee and Selgrade descendants is noted.
- The paper states that no existing model incorporates on/off dosing regimens or metabolism of exogenous hormones, and only Gavina et al. explores time-varying exogenous hormones; Gavina et al.’s optimal dosing schedules may not be biologically feasible, such as a large mid-follicular estrogen spike.
- The paper notes that large models raise parameter-identification and overfitting concerns and are less amenable to mathematical analysis; several models track only inhibin A and not inhibin B, and the Harris Clark and Margolskee models were not designed primarily for hormonal contraception, so their contraceptive effects are not strongly captured.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Schematic time courses of hormone levels throughout the menstrual cycle based on data by Welt et al. [12]](https://figures.cochat.ai/paper-figures/61c9c59b71d74480aafd8ec99abb46e6/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-2.png)

![Fig. 4 Numerical solutions to the Harris Clark et al. [41] model plotted against data from McLachlan et al. [9]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 30.1 days. Note that the units for the hormone levels mirror the units reported in the McLachlan et al. data set](https://figures.cochat.ai/paper-figures/435ff979ecb7449693d4d849e0ad2641/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-4.png)
![Fig. 5 Numerical solutions to the Margolskee and Selgrade [45] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set](https://figures.cochat.ai/paper-figures/fb49e73619604825a68f12d6a7f59047/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-5.png)
![Fig. 6 Numerical solutions to the Wright et al. [46] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28.7 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set](https://figures.cochat.ai/paper-figures/57d991d5c08a41a59c82a040be72f565/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-6.png)
![Fig. 7 Numerical solutions to the Gavina et al. [47] model plotted against data from Welt et al. [12]. The root mean square error (RMSE) for each variable is shown, and the period is computed to be approximately 28 days. The units for the hormone levels in these plots reflect the units reported in the Welt et al. data set](https://figures.cochat.ai/paper-figures/8f96ff5cdfa84630b23782050b570dc0/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-7.png)


![Fig. 10 LH peak concentration and menstrual cycle period for the various models [41, 4547] with daily administration of exogenous hormones, i.e., hormonal contraceptives. We vary the amount of exogenous estrogen . e dose up to its mean concentration (horizontal axis) and exogenous progesterone . p dose up to 30% of its mean concentration (vertical axis) in each model. In panels A-D, we visualize the effects of . e dose and . p dose on LH peak concentrations, with yellow representing high peak concentrations of LH and blue representing low peak concentrations of LH. These blue values represent the parameter ranges where the model is in a contraceptive state. In panels E-H, we visualize the effects of . e dose and . p dose on the period of P . 4 oscillations, with yellow representing a longer cycle length and red representing a shorter cycle length. The white regions in these plots correspond to the absence of oscillations, which indicates that the model is in a total contraceptive state. Schematic plots of example 28-day hormone trajectories corresponding to contraceptive states for the Wright et al. [46] model are provided in panels i ( . p dose = 0 . 6) and ii ( . p dose = 1 . 3), which correspond to the dots indicated in panel C. Simulations were run for 100 cycles before each computation to help eliminate the effects of transient initialization behavior](https://figures.cochat.ai/paper-figures/870931918c8d45acaea2a3f9e83c8e9d/a-survey-of-mathematical-modeling-of-hormonal-contraception-and-the-menstrual-figure-10.png)
Verification
Claims the paper makes
27 Valid · 5 Not valid · 52 Not checked · 32 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Utilized optimal control theory on a modified menstrual cycle model (based on Margolskee 2011 model) to determine the minimum total exogenous estrogen/progesterone dose and timing of administration to induce anovulation (absence of ovulation)”
What the sources say
- Partly supportedcites [11] A. Obruca, T. Korver, J. Huber, S.R. Killick, B.M. Landgren, M.J. Struijs, Fertil. Steril. 76(1), 108 (2001) sourceExperimental — accuracy not yet measured
The conclusion (FERTILITY & STERILITY section; page not provided) reports that daily doses of Org 30659 inhibited ovulation. It does not report using a Margolskee-based menstrual-cycle model or optimal control theory to determine a minimum combined estrogen/progesterone dose or its timing; searches for those methods found no supporting passage. (LLM, conf=0.82)
- Not matchedcites [12] C.K. Welt, D.J. McNicholl, A.E. Taylor, J.E. Hall, J. Clin. Endocrinol. Metab. 84(1), 105 (1999)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Could not verifycites [60] S. Deb, B. Campbell, C. Pincott-Allen, J. Clewes, G. Cumberpatch, N. Raine-Fenning, Ultrasound Obstetr. Gynecol. 39(5), 574 (2012) sourceExperimental — accuracy not yet measured
The Introduction and Study design describe a comparison of contraceptive-pill users with nonusers to assess ovarian-reserve markers. Searches for the Margolskee model, optimal control, and minimum hormone-dose timing found no passage describing the claimed modeling or optimization; page numbers were not available in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [61] S.E. Monroe, M.R. Henzl, M.C. Martin, E. Schriock, V. Lewis, C. Nerenberg, R.B. Jaffe, Fertil. Steril. 43(8), 361 (1985) source
- Not checked — no full text of the sourcecites [62] S.E. Monroe, Z. Blumenfeld, J.L. Andreyko, E. Schriock, M.R. Henzl, R.B. Jaffe, J. Clin. Endocrinol. Metab. 63(6), 1334 (1986) source
- Disputedcites [63] I.J.M. Duijkers, C. Klipping, W.N.P. Willemsen, D. Krone, E. Schneider, G. Niebch, R. Hermann, Hum. Reprod. 13(9), 2392 (1998) sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that ovulation was postponed, not prevented. The paper reports an experiment administering Cetrorelix to healthy volunteers, rather than using optimal control of exogenous estrogen and progesterone to induce anovulation. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [64] I. Leroy, M.F. d’Acremont, S. Brailly-Tabard, R. Frydman, J. deMouzon, P. Bouchard, Fertil. Steril. 62(3), 461 (1994) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The model extended the Margolskee and Selgrade [45] and Harris Clark et al. [41] models by adding autocrine mechanisms to describe how exogenous estrogen and progesterone could push a normal cycle into a contraceptive state.”
What the sources say
- Supportedcites [45] A. Margolskee, J.F. Selgrade, Math. Biosci. 234(2), 95 (2011) source
The Introduction and §2, “Biological Background and Model Equations,” describe the menstrual-cycle model developed and studied in this paper. The citation identifies the Margolskee and Selgrade model as a predecessor; the sentence attributes the autocrine additions and contraceptive-state application to the later Wright et al. model, not to this source. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [41] L.H. Clark, P.M. Schlosser, J.F. Selgrade, Bull. Math. Biol. 65(1), 157 (2003) source
- Supportedcites [46] A.A. Wright, G.N. Fayad, J.F. Selgrade, M.S. Olufsen, PLoS Comput. Biol. 16(6), e1007848 (2020) source
The Introduction says the Clark et al. and Margolskee and Selgrade models lacked ovarian autocrine effects, and that this study's model adds them to test exogenous estrogen and progestin treatments. The Methods section on contraceptive mechanisms describes how the added mechanisms allow the model to reproduce contraceptive behavior that the earlier models could not. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This model also included a system of nonlinear delay differential equations with four auxiliary equations representing the ovarian hormones E . 2, P . 4, and inhibin A.”
What the sources say
- Supportedcites [46] A.A. Wright, G.N. Fayad, J.F. Selgrade, M.S. Olufsen, PLoS Comput. Biol. 16(6), e1007848 (2020) source
The Methods section (page unavailable) identifies four auxiliary equations, Eqs (14)–(17), for ovarian hormone calculations, including estrogen, progesterone and its derived signal Papp; the model also uses inhibin A. The Results section on bifurcation analysis (page unavailable) identifies the system as delay differential equations, while the Methods describe nonlinear Hill-function terms. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Selgrade and Schlosser's model systems [7, 8] together form the foundation for a number of subsequent modeling efforts [41-43, 51].”
What the sources say
- Not matchedcites [7] J.F. Selgrade, P.M. Schlosser, Fields Inst. Commun. 21, 429 (1999)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [8] P.M. Schlosser, J.F. Selgrade, Environ. Health Perspect. 108(Suppl 5), 873 (2000) source
- Not checked — no full text of the sourcecites [41] L.H. Clark, P.M. Schlosser, J.F. Selgrade, Bull. Math. Biol. 65(1), 157 (2003) source
- Not matchedcites [42] L.A. Harris, Differential Equation Models for the Hormonal Regulation of the Menstrual Cycle. Ph.D. thesis, North Carolina State University (2002)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [43] R.D. Pasteur, J.F. Selgrade, in Understanding the Dynamics of Biological Systems (Springer, New York, 2011), pp. 39–58 source
- Supportedcites [51] I. Reinecke, Mathematical Modeling and Simulation of the Female Menstrual Cycle. Ph.D. thesis, Freien Universität Berlin (2009) source
The Model Development–GynCycle chapter says an earlier menstrual-cycle model provides the basis for Reinecke’s further modeling. Section 2.1 identifies that model as Harris’s compartment model and cites Selgrade and Schlosser’s work among its underlying assumptions. Reinecke’s dissertation therefore supports the citation’s role as an example of a subsequent modeling effort, rather than as evidence for the total number of such efforts. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Of this collection of modeling efforts, the models first developed by Selgrade, Schlosser, and Harris Clark [7, 8, 41, 42] stand out because they have been used as the foundation for a significant number of subsequent models [43-47].”
What the sources say
- Not matchedcites [7] J.F. Selgrade, P.M. Schlosser, Fields Inst. Commun. 21, 429 (1999)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [8] P.M. Schlosser, J.F. Selgrade, Environ. Health Perspect. 108(Suppl 5), 873 (2000) source
- Not checked — no full text of the sourcecites [41] L.H. Clark, P.M. Schlosser, J.F. Selgrade, Bull. Math. Biol. 65(1), 157 (2003) source
- Not matchedcites [42] L.A. Harris, Differential Equation Models for the Hormonal Regulation of the Menstrual Cycle. Ph.D. thesis, North Carolina State University (2002)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [43] R.D. Pasteur, J.F. Selgrade, in Understanding the Dynamics of Biological Systems (Springer, New York, 2011), pp. 39–58 source
- Not matchedcites [44] R.D. Pasteur II, A Multiple-Inhibin Model of the Human Menstrual Cycle. Ph.D. thesis, North Carolina State University (2008)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [45] A. Margolskee, J.F. Selgrade, Math. Biosci. 234(2), 95 (2011) source
The Introduction identifies models by Selgrade, Schlosser, and Harris-Clark and says their work led to a 13-dimensional model. The Biological Background and Model Equations section uses that model as the basis for this paper's analysis. As a citation to one example among several subsequent models [43–47], this paper supports the claim; it need not establish the total number on its own. (LLM, conf=0.88)
- Supportedcites [46] A.A. Wright, G.N. Fayad, J.F. Selgrade, M.S. Olufsen, PLoS Comput. Biol. 16(6), e1007848 (2020) source
The Introduction says many mathematical models of normal cycling are based on the formulation by Schlosser and Selgrade and identifies Clark et al. among the earlier models. The Methods describe this paper’s model as based on a later model in that lineage, making it an example of a subsequent model built on that foundation. (LLM, conf=0.92)
- Supportedcites [47] B.L.A. Gavina, A.A. de los Reyes V, M.S. Olufsen, S. Lenhart, J.T. Ottesen, PLoS Comput. Biol. 19(4), e1010073 (2023) source
The Introduction calls the work stemming from Selgrade and collaborators the most significant body of menstrual-cycle modeling work, then describes extensions by Pasteur, Margolskee, and Wright. It also states that this paper expands earlier models in that line of work, supporting the claim that the foundational models underlie numerous subsequent models. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
63 more claims · 9 with their cited sources checked
Create a free account to see all 116 claims and every source verdict.
- Probably not a substantial claim. 34
- It may state two separate claims as one. 19
Citations
Cites
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2007) · W.W. Norton eBooks · doi:10.1201/9780203833445 · Cited by 4,589
The Hopf Bifurcation and Its Applications
Marsden, J. E., & McCracken, M. (1976) · Applied Mathematical Sciences · doi:10.1007/978-1-4612-6374-6 · Cited by 2,300
The Hopf Bifurcation and Its Applications
Marsden, J., Mccracken, M., Sethna, P. R., & Sell, G. (1976) · doi:10.1115/1.3424264 · Cited by 2,047
Yonkers, K. A., O'Brien, P. S., & Eriksson, E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60527-9 · Cited by 541
The normal menstrual cycle in women
Mihm, M., Gangooly, S., & Muttukrishna, S. (2011) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2010.08.030 · Cited by 448
Real-world menstrual cycle characteristics of more than 600,000 menstrual cycles
Bull, J. R., Rowland, S. P., Scherwitzl, E. B., Scherwitzl, R., Danielsson, K. G., & Harper, J. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0152-7 · Cited by 404
The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices
Rivera, R., Yacobson, I., & Grimes, D. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70120-1 · Cited by 400
Stricker, R., Eberhart, R., Chevailler, M.-C., Quinn, F. A., Bischof, P., & Stricker, R. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.160 · Cited by 392
The dynamics of the primordial follicle reserve
Kerr, J. B., Myers, M., & Anderson, R. A. (2013) · Reproduction · doi:10.1530/rep-13-0181 · Cited by 182
Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
Mulders, T. M. T., & Dieben, T. O. M. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01689-2 · Cited by 170
Research works printed but not linked: 12
- J.F. Selgrade, P.M. Schlosser, Fields Inst. Commun. 21, 429 (1999)
- C.K. Welt, D.J. McNicholl, A.E. Taylor, J.E. Hall, J. Clin. Endocrinol. Metab. 84(1), 105 (1999)
- B.G. Reed, B.R. Carr, The Normal Menstrual Cycle and the Control of Ovulation (MDText, South Dartmouth, MA, 2000). http://europepmc.org/books/NBK279054
- E.A. McGee, A.J.W. Hsueh, Endocr. Rev. 21(2), 200 (2000)
- C.K. Welt, A.L. Schneyer, J. Clin. Endocrinol. Metab. 86(1), 330 (2001)
- A. Sehested, A.A. Juul, A.M. Andersson, J.H. Petersen, T.K. Jensen, J. Müller, N.E. Skakkebaek, J. Clin. Endocrinol. Metab. 85, 1634 (2000)
- L.A. Harris, Differential Equation Models for the Hormonal Regulation of the Menstrual Cycle. Ph.D. thesis, North Carolina State University (2002)
- R.D. Pasteur II, A Multiple-Inhibin Model of the Human Menstrual Cycle. Ph.D. thesis, North Carolina State University (2008)
- H.B. Lavoie, K.A. Martin, A.E. Taylor, W.F. Crowley, J.E. Hall, J. Clin. Endocrinol. Metab. 83(1), 241 (1998)
- A. Sehested, A. Juul, A.M. Andersson, J.H. Petersen, T.K. Jensen, J. Müller, N.E. Skakkebaek, J. Clin. Endocrinol. Metab. 85(4), 1634 (2000)
- N.P. Groome, P.J. Illingworth, M. O’Brien, R. Pai, F. Rodger, J. Mather, A. McNeilly, J. Clin. Endocrinol. Metab. 81(4), 1401 (1996)
- W. Odell, The Reproductive System in Women (Grune & Stratton, New York, 1979), pp. 1383–1400
Cited by
Modeling for the menstrual cycle with non-local operators
Mishra, J. (2025) · Partial Differential Equations in Applied Mathematics · doi:10.1016/j.padiff.2025.101128
Optimizing oral contraceptive timing: Daytime intake reduces doses and enhances efficacy
Gavina, B. L. A., Lee, T., Cawiding, O. R., Choi, S., Choi, S., Kim, S., & Kim, J. K. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014040
Metadata
- Authors
- Zhao, L., Kim, R., Oremland, L. S., Chowkwale, M., Pillis, L. G. D., & Brooks, H. Z.
- Affiliations
- University of California, Merced (US)
- University of Michigan (US)
- Skidmore College (US)
- University of Virginia (US)
- Harvey Mudd College (US)
- Corresponding author
- Zhao, Lihong
- Venue
- The IMA volumes in mathematics and its applications
- Publisher
- Springer Nature Switzerland
- Published
- 2024
- Pages
- 51-82
- ISSN
- 0940-6573 (ISSN-L)
- 2198-3224
- OpenAlex
- W4400691506
- Cited by
- 2
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1
- FWCI
- 5.32
- Type
- book chapter
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 87 d)
- Locations
- The IMA volumes in mathematics and its applications (publishedVersion, cc-by)
- Funders
- University of Minnesota
- UnitedHealth Group
- Topics
- Physical Sciences › Mathematics › Applied Mathematics › Mathematical and Theoretical Epidemiology and Ecology Models
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- menstrual cycle, hormonal contraception, follicle-stimulating hormone, reserve pool, parameter sensitivity, time delay, exogenous hormones, model comparison
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle. https://app.cochat.ai/papers/10.1007/978-3-031-58516-6_3
- The paper
- Zhao, L., Kim, R., Oremland, L. S., Chowkwale, M., Pillis, L. G. D., & Brooks, H. Z. (2024). A Survey of Mathematical Modeling of Hormonal Contraception and the Menstrual Cycle. The IMA volumes in mathematics and its applications. https://doi.org/10.1007/978-3-031-58516-6_3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.